Summary of Significant Accounting Policies (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Summary of Significant Accounting Policies [Line Items] | ||||||
| Estimated credit losses | $ 9,023,768 | $ 223,166 | ||||
| Advertising costs | 1,349,794 | 491,596 | ||||
| Research and development costs | $ 733,616 | $ 1,957,352 | $ 1,870,845 | $ 3,647,506 | 7,086,087 | 1,911,031 |
| Accounts receivable | $ 18,642,078 | $ 23,099,404 | ||||
| US statutory rate | 21.00% | 21.00% | ||||
| Percentage of quantitative threshold | 5.00% | |||||
| Percentage of reconciling items | 1.05% | |||||
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | ||||||
| Summary of Significant Accounting Policies [Line Items] | ||||||
| Concentration Risk, Percentage | 100.00% | 100.00% | ||||
| One customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | ||||||
| Summary of Significant Accounting Policies [Line Items] | ||||||
| Concentration Risk, Percentage | 99.00% | 98.00% | ||||
| X | ||||||||||
- Definition Percentage of quantitative threshold. No definition available.
|
| X | ||||||||||
- Definition Percentage of quantitative threshold. No definition available.
|
| X | ||||||||||
- Definition Amount of decrease from sale of accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of allowance for credit loss on receivable, classified as other and current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|